Financial Statements — LABT
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 2.58 | 0.01 |
| Short-term Investments | 2.00 | -- |
| Total Current Assets | 4.85 | 0.05 |
| Property, Plant & Equipment | 0.01 | 0.01 |
| Total Non-current Assets* | 0.11 | 0.15 |
| Total Assets | 4.96 | 0.20 |
| Accounts Payable | 0.17 | 0.55 |
| Total Current Liabilities | 0.63 | 3.03 |
| Total Non-current Liabilities* | 0.00 | 0.01 |
| Total Liabilities | 0.63 | 3.04 |
| Retained Earnings | (68.64) | (54.27) |
| Total Stockholder Equity | 4.33 | (2.84) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cost of Revenue | -- | 0.51 |
| Research & Development | 0.50 | 0.18 |
| Selling, General & Admin | 3.29 | 0.70 |
| Total Operating Expenses | 3.79 | 0.89 |
| Operating Income | (3.79) | (0.89) |
| Net Income | (3.77) | (0.92) |
| Basic EPS | (2.75) | (0.20) |
| Diluted EPS | (2.75) | (0.20) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (2.10) | (0.35) |
| Investing Cash Flow | (2.00) | -- |
| Financing Cash Flow | 6.68 | 0.13 |
